SUCCESS Tracking Study
Status: | Terminated |
---|---|
Conditions: | Obesity Weight Loss |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 69 |
Updated: | 8/30/2017 |
Start Date: | March 2008 |
End Date: | July 2014 |
Weight Loss & Maintenance of Weight Loss Tracking Study (SUCCESS Tracking Study)
The overall purpose of this research is to evaluate the long-term outcomes associated with
participation in Medifast Direct and Take Shape For Life weight-loss programs in comparison
with non-Medifast weight-loss programs. Another important goal of this research is to
determine whether the differences between Medifast Direct and Take Shape For Life programs
affect weight-loss and maintenance of weight-loss in customers.
participation in Medifast Direct and Take Shape For Life weight-loss programs in comparison
with non-Medifast weight-loss programs. Another important goal of this research is to
determine whether the differences between Medifast Direct and Take Shape For Life programs
affect weight-loss and maintenance of weight-loss in customers.
Researchers desire to capture the behaviors and outcomes of those individuals who would
enroll in these programs without the additional encouragement to be a participant in a
research study. The study will employ an observational prospective design intended to
introduce as little interference as possible with subjects' behaviors. This is in order to
capture the pure effects of the weight-loss programs themselves, and to reduce the
potentially confounding effects of merely participating in a research study. Subjects who
have already committed to a weight-loss program (Medifast Direct, Take Shape For Life , or
other) will be recruited to join this study, and will be asked to complete several
questionnaires over a period of up to 6 ⅓ years after enrollment. Questionnaires will measure
information regarding anthropometrics, sociodemographics, and health & quality of life
outcomes. The overall goal of this research is to be able to describe and compare the
long-term dieting behaviors and outcomes among participants in Medifast Direct and Take Shape
For Life programs in comparison with other dieters.
enroll in these programs without the additional encouragement to be a participant in a
research study. The study will employ an observational prospective design intended to
introduce as little interference as possible with subjects' behaviors. This is in order to
capture the pure effects of the weight-loss programs themselves, and to reduce the
potentially confounding effects of merely participating in a research study. Subjects who
have already committed to a weight-loss program (Medifast Direct, Take Shape For Life , or
other) will be recruited to join this study, and will be asked to complete several
questionnaires over a period of up to 6 ⅓ years after enrollment. Questionnaires will measure
information regarding anthropometrics, sociodemographics, and health & quality of life
outcomes. The overall goal of this research is to be able to describe and compare the
long-term dieting behaviors and outcomes among participants in Medifast Direct and Take Shape
For Life programs in comparison with other dieters.
Inclusion Criteria:
- Adult males and females between the ages of 18 - 69 years
- BMI ( > 25.0 kg/m2)
- Beginning a weight loss diet plan (MD, TSFL, or one of a number of commercially
available plans)NOTE: subjects must have already committed to a weight-loss plan in
order to be eligible for this study. The recruitment process is specifically designed
so as NOT to appear to encourage subjects to begin a weight-loss plan. Rather, the
purpose of this research is to track information about persons who have already
committed to a weight-loss program.
- Willing and able to give informed consent
- Willing and able to comply with study protocol
Exclusion Criteria:
- Unable to give informed consent
- Previous hospitalization for psychiatric disorder or eating disorder
- Current, uncontrolled medical conditions
- Taking unstable doses of weight-loss or appetite-affecting medications (e.g., SSRIs,
steroids, Ritalin)
- Taking prescription weight-loss drugs (Phentermine, Sibutramine, Orlistat, etc…)
- Have undergone, or plan to undergo, weight loss surgery (e.g. gastric bypass, lap
band, duodenal switch) in the next 6 1/3 years
- Plan to undergo weight-altering cosmetic surgery procedures (e.g. breast
reduction/augmentation, tummy tuck, liposuction, or other skin removal procedures) in
the next 6 1/3 years
We found this trial at
1
site
Click here to add this to my saved trials